CASI Pharma (CASI) Tops Q1 EPS by 1c

CASI Pharma (NASDAQ: CASI) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

As of March 31, 2016, CASI had cash and cash equivalents of $13.9 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Kotak Starts INDO-MIM Ltd (INDOMIM:IN) at Reduce (3)
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold